Hao Wang

Associate Professor

20012019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hao Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., Gaver, M., Wang, H., Denmeade, S., Lotan, T., Paller, C., Markowski, M., Carducci, M., Eisenberger, M., Beer, T. M., Song, D. Y., Deweese, T. L., Hearn, J. W., Greco, S., Deville, C. & 7 others, Desai, N. B., Heath, E. I., Liauw, S., Spratt, D. E., Hung, A. Y., Antonarakis, E. S. & Tran, P. T., Jun 13 2019, In : BMC cancer. 19, 1, 572.

Research output: Contribution to journalArticle

Open Access
Salvage Therapy
Prostatectomy
Double-Blind Method
Prostatic Neoplasms
Radiotherapy
Open Access
Mesenchymal Stromal Cells
Prostatic Neoplasms
Bone Marrow
Safety
Neoplasms

Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis

Lu, S., Stein, J. E., Rimm, D. L., Wang, D. W., Bell, J. M., Johnson, D. B., Sosman, J. A., Schalper, K. A., Anders, R. A., Wang, H., Hoyt, C., Pardoll, D. M., Danilova, L. & Taube, J. M., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalReview article

CD274 Antigen
Meta-Analysis
Biomarkers
Immunohistochemistry
Gene Expression Profiling
Consultants
Oncogenes
T-Lymphocytes
Conflict of Interest
Organized Financing

Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response

Mandal, R., Samstein, R. M., Lee, K. W., Havel, J. J., Wang, H., Krishna, C., Sabio, E. Y., Makarov, V., Kuo, F., Blecua, P., Ramaswamy, A. T., Durham, J. N., Bartlett, B., Ma, X., Srivastava, R., Middha, S., Zehir, A., Hechtman, J. F., Morris, L. G., Weinhold, N. & 4 others, Riaz, N., Le, D. T., Diaz, L. A. & Chan, T. A., May 3 2019, In : Science (New York, N.Y.). 364, 6439, p. 485-491 7 p.

Research output: Contribution to journalArticle

Immunotherapy
Cell Death
Microsatellite Instability
Neoplasms
Tumor Burden